Global In Vitro Diagnostics (IVD) Market 2021-2031

Bonafide Trust 06-09-2022 194 Pages
Region : Global Category : Lifescience Medical Devices

New Report Guarantee

If you purchase this report now and we update it in new 100 days, get it free!

Report Description
Table of Contents
List of Figure Tables

Global in vitro diagnostics (IVD) market will reach $148,393.3 million by 2031, growing by 6.3% annually over 2021-2031, driven by the increasing prevalence of chronic diseases along with the growing geriatric population, burgeoning demand for automation in diagnostics, the rising development of condition-specific treatment and booming awareness regarding personalized medicines, emergence of minimally invasive and non-invasive diagnostics tools & techniques, the rising healthcare expenditure, and rise in the demand for POC testing. Highlighted with 84 tables and 96 figures, this 194-page report “Global In Vitro Diagnostics (IVD) Market 2021-2031 by Product (Instruments & Devices, Reagents & Kits, Software & Services), Technology (Clinical Chemistry, Molecular Diagnostics, Immuno Diagnostics), Sample Type (Blood, Mucus, Urine), Application (Infectious Diseases, Diabetes, Cancer/Oncology), End User (Diagnostic Labs, Hospitals and Clinics, Homecare, POC), and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global in vitro diagnostics (IVD) market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify global in vitro diagnostics (IVD) market in every aspect of the classification from perspectives of Product, Technology, Sample Type, Application, End User, and Region. Based on Product, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Instruments & Devices o Disposable IVD Devices o Reusable IVD Devices • Reagents & Kits • Software & Services Based on Technology, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Clinical Chemistry • Molecular Diagnostics • Immuno Diagnostics • Hematology • Tissue Diagnostics • Microbiology • Coagulation and Hemostasis • Urinalysis • Other Technologies By Sample Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Blood • Mucus • Urine • Other Sample Types By Application, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Infectious Diseases • Diabetes • Cancer/Oncology • Cardiology • Autoimmune Disease • Nephrology • Drug Testing • HIV/AIDS • Other Applications By End User, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Diagnostic Laboratories • Hospitals and Clinics • Homecare Settings • Point-of-Care (POC) Settings • Other End Users Geographically, the following regions together with the listed national/local markets are fully investigated: • North America (U.S., Canada, and Mexico) • Europe (Germany, UK, France, Spain, Italy, Netherlands, Rest of Europe; Rest of Europe is further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland) • APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines) • South America (Brazil, Chile, Argentina, Rest of South America) • MEA (UAE?Saudi Arabia, South Africa and Rest of MEA) For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of all regional markets by country and split of each national market by Product, Application and End User over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Selected Key Players: Abbott Laboratories, Inc. Agilent Technologies, Inc. Arkray Inc. Becton, Dickinson and Company Biomerieux SA Bio-Rad Laboratories Inc. Danaher Corporation DiaSorin SpA (Luminex Corporation) Epic Systems Corporation F. Hoffmann-La Roche Ltd. Genpact Limited Grifols SA IBM Corporation Mckesson Corporation Ortho Clinical Diagnostics Inc. Qiagen NV Quest Diagnostics Inc. Quidel Corporation Roche Diagnostics Siemens Healthineers Sysmex Corporation Thermo Fisher Scientific Inc. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

1 Introduction 10

1.1 Industry Definition and Research Scope 10

1.1.1 Industry Definition 10

1.1.2 Research Scope 11

1.2 Research Methodology 14

1.2.1 Overview of Market Research Methodology 14

1.2.2 Market Assumption 15

1.2.3 Secondary Data 15

1.2.4 Primary Data 15

1.2.5 Data Filtration and Model Design 16

1.2.6 Market Size/Share Estimation 17

1.2.7 Research Limitations 18

1.3 Executive Summary 19

2 Market Overview and Dynamics 22

2.1 Market Size and Forecast 22

2.1.1 Impact of COVID-19 on World Economy 23

2.1.2 Impact of COVID-19 on the Market 27

2.2 Major Growth Drivers 29

2.3 Market Restraints and Challenges 35

2.4 Emerging Opportunities and Market Trends 38

2.5 Porter’s Fiver Forces Analysis 42

3 Segmentation of Global Market by Product 46

3.1 Market Overview by Product 46

3.2 Instruments & Devices 48

3.2.1 Disposable IVD Devices 49

3.2.2 Reusable IVD Devices 50

3.3 Reagents & Kits 51

3.4 Software & Services 52

4 Segmentation of Global Market by Technology 53

4.1 Market Overview by Technology 53

4.2 Clinical Chemistry 55

4.3 Molecular Diagnostics 56

4.4 Immuno Diagnostics 57

4.5 Hematology 58

4.6 Tissue Diagnostics 59

4.7 Microbiology 60

4.8 Coagulation and Hemostasis 61

4.9 Urinalysis 62

4.10 Other Technologies 63

5 Segmentation of Global Market by Sample Type 64

5.1 Market Overview by Sample Type 64

5.2 Blood 66

5.3 Mucus 67

5.4 Urine 68

5.5 Other Sample Types 69

6 Segmentation of Global Market by Application 70

6.1 Market Overview by Application 70

6.2 Infectious Diseases 72

6.3 Diabetes 82

6.4 Cancer/Oncology 83

6.5 Cardiology 84

6.6 Autoimmune Disease 85

6.7 Nephrology 86

6.8 Drug Testing 87

6.9 HIV/AIDS 88

6.10 Other Applications 89

7 Segmentation of Global Market by End User 90

7.1 Market Overview by End User 90

7.2 Diagnostic Laboratories 92

7.3 Hospitals and Clinics 93

7.4 Homecare Settings 94

7.5 Point-of-Care (POC) Settings 95

7.6 Other End Users 96

8 Segmentation of Global Market by Region 97

8.1 Geographic Market Overview 2021-2031 97

8.2 North America Market 2021-2031 by Country 101

8.2.1 Overview of North America Market 101

8.2.2 U.S. 105

8.2.3 Canada 108

8.2.4 Mexico 110

8.3 European Market 2021-2031 by Country 112

8.3.1 Overview of European Market 112

8.3.2 Germany 116

8.3.3 U.K. 118

8.3.4 France 120

8.3.5 Spain 122

8.3.6 Italy 124

8.3.7 Netherlands 126

8.3.8 Rest of European Market 128

8.4 Asia-Pacific Market 2021-2031 by Country 130

8.4.1 Overview of Asia-Pacific Market 130

8.4.2 Japan 134

8.4.3 China 137

8.4.4 Australia 139

8.4.5 India 141

8.4.6 South Korea 143

8.4.7 Rest of APAC Region 145

8.5 South America Market 2021-2031 by Country 147

8.5.1 Argentina 150

8.5.2 Brazil 152

8.5.3 Chile 154

8.5.4 Rest of South America Market 156

8.6 MEA Market 2021-2031 by Country 157

8.6.1 UAE 160

8.6.2 Saudi Arabia 162

8.6.3 South Africa 164

8.6.4 Other National Markets 166

9 Competitive Landscape 167

9.1 Overview of Key Vendors 167

9.2 New Product Launch, Partnership, Investment, and M&A 170

9.3 Company Profiles 171

Abbott Laboratories, Inc. 171

Agilent Technologies, Inc. 173

Arkray Inc. 174

Becton, Dickinson and Company 175

Biomerieux SA 176

Bio-Rad Laboratories Inc. 177

Danaher Corporation 178

DiaSorin SpA (Luminex Corporation) 179

Epic Systems Corporation 180

F. Hoffmann-La Roche Ltd. 181

Genpact Limited 182

Grifols SA 183

IBM Corporation 184

Mckesson Corporation 185

Ortho Clinical Diagnostics Inc. 186

Qiagen NV 187

Quest Diagnostics Inc. 188

Quidel Corporation 189

Roche Diagnostics 190

Siemens Healthineers 191

Sysmex Corporation 192

Thermo Fisher Scientific Inc. 193

RELATED REPORTS 194

List of Tables:

Table 1. Snapshot of Global In Vitro Diagnostics Market in Balanced Perspective, 2021-2031 20
Table 2. World Economic Outlook, 2021-2031 24
Table 3. World Economic Outlook, 2021-2023 25
Table 4. World Health Spending by Region, $ bn, 2013-2020 34
Table 5. Main Product Trends and Market Opportunities in Global In Vitro Diagnostics Market 38
Table 6. Global In Vitro Diagnostics Market by Product, 2021-2031, $ mn 46
Table 7. Global In Vitro Diagnostics Market: Instruments & Devices by Type, 2021-2031, $ mn 48
Table 8. Global In Vitro Diagnostics Market by Technology, 2021-2031, $ mn 53
Table 9. Global In Vitro Diagnostics Market by Sample Type, 2021-2031, $ mn 64
Table 10. Global In Vitro Diagnostics Market by Application, 2021-2031, $ mn 70
Table 11. Commercially Available COVID-19 Diagnostic Tests Approved in 2021-2022 73
Table 12. Global In Vitro Diagnostics Market by End User, 2021-2031, $ mn 90
Table 13. Global In Vitro Diagnostics Market by Region, 2021-2031, $ mn 98
Table 14. Leading National In Vitro Diagnostics Market, 2021 and 2031, $ mn 100
Table 15. North America In Vitro Diagnostics Market by Country, 2021-2031, $ mn 103
Table 16. U.S. In Vitro Diagnostics Market by Product, 2021-2031, $ mn 107
Table 17. U.S. In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn 107
Table 18. U.S. In Vitro Diagnostics Market by End User, 2021-2031, $ mn 107
Table 19. Canada In Vitro Diagnostics Market by Product, 2021-2031, $ mn 109
Table 20. Canada In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn 109
Table 21. Canada In Vitro Diagnostics Market by End User, 2021-2031, $ mn 109
Table 22. Mexico In Vitro Diagnostics Market by Product, 2021-2031, $ mn 111
Table 23. Mexico In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn 111
Table 24. Mexico In Vitro Diagnostics Market by End User, 2021-2031, $ mn 111
Table 25. Europe In Vitro Diagnostics Market by Country, 2021-2031, $ mn 115
Table 26. Germany In Vitro Diagnostics Market by Product, 2021-2031, $ mn 117
Table 27. Germany In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn 117
Table 28. Germany In Vitro Diagnostics Market by End User, 2021-2031, $ mn 117
Table 29. U.K. In Vitro Diagnostics Market by Product, 2021-2031, $ mn 119
Table 30. U.K. In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn 119
Table 31. U.K. In Vitro Diagnostics Market by End User, 2021-2031, $ mn 119
Table 32. France In Vitro Diagnostics Market by Product, 2021-2031, $ mn 121
Table 33. France In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn 121
Table 34. France In Vitro Diagnostics Market by End User, 2021-2031, $ mn 121
Table 35. Spain In Vitro Diagnostics Market by Product, 2021-2031, $ mn 123
Table 36. Spain In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn 123
Table 37. Spain In Vitro Diagnostics Market by End User, 2021-2031, $ mn 123
Table 38. Italy In Vitro Diagnostics Market by Product, 2021-2031, $ mn 125
Table 39. Italy In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn 125
Table 40. Italy In Vitro Diagnostics Market by End User, 2021-2031, $ mn 125
Table 41. Netherlands In Vitro Diagnostics Market by Product, 2021-2031, $ mn 127
Table 42. Netherlands In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn 127
Table 43. Netherlands In Vitro Diagnostics Market by End User, 2021-2031, $ mn 127
Table 44. In Vitro Diagnostics Market in Rest of Europe by Country, 2021-2031, $ mn 129
Table 45. APAC In Vitro Diagnostics Market by Country, 2021-2031, $ mn 132
Table 46. Japan In Vitro Diagnostics Market by Product, 2021-2031, $ mn 136
Table 47. Japan In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn 136
Table 48. Japan In Vitro Diagnostics Market by End User, 2021-2031, $ mn 136
Table 49. China In Vitro Diagnostics Market by Product, 2021-2031, $ mn 138
Table 50. China In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn 138
Table 51. China In Vitro Diagnostics Market by End User, 2021-2031, $ mn 138
Table 52. Australia In Vitro Diagnostics Market by Product, 2021-2031, $ mn 140
Table 53. Australia In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn 140
Table 54. Australia In Vitro Diagnostics Market by End User, 2021-2031, $ mn 140
Table 55. India In Vitro Diagnostics Market by Product, 2021-2031, $ mn 142
Table 56. India In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn 142
Table 57. India In Vitro Diagnostics Market by End User, 2021-2031, $ mn 142
Table 58. South Korea In Vitro Diagnostics Market by Product, 2021-2031, $ mn 144
Table 59. South Korea In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn 144
Table 60. South Korea In Vitro Diagnostics Market by End User, 2021-2031, $ mn 144
Table 61. In Vitro Diagnostics Market in Rest of APAC by Country/Region, 2021-2031, $ mn 146
Table 62. South America In Vitro Diagnostics Market by Country, 2021-2031, $ mn 149
Table 63. Argentina In Vitro Diagnostics Market by Product, 2021-2031, $ mn 151
Table 64. Argentina In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn 151
Table 65. Argentina In Vitro Diagnostics Market by End User, 2021-2031, $ mn 151
Table 66. Brazil In Vitro Diagnostics Market by Product, 2021-2031, $ mn 153
Table 67. Brazil In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn 153
Table 68. Brazil In Vitro Diagnostics Market by End User, 2021-2031, $ mn 153
Table 69. Chile In Vitro Diagnostics Market by Product, 2021-2031, $ mn 155
Table 70. Chile In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn 155
Table 71. Chile In Vitro Diagnostics Market by End User, 2021-2031, $ mn 155
Table 72. MEA In Vitro Diagnostics Market by Country, 2021-2031, $ mn 159
Table 73. UAE In Vitro Diagnostics Market by Product, 2021-2031, $ mn 161
Table 74. UAE In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn 161
Table 75. UAE In Vitro Diagnostics Market by End User, 2021-2031, $ mn 161
Table 76. Saudi Arabia In Vitro Diagnostics Market by Product, 2021-2031, $ mn 163
Table 77. Saudi Arabia In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn 163
Table 78. Saudi Arabia In Vitro Diagnostics Market by End User, 2021-2031, $ mn 163
Table 79. South Africa In Vitro Diagnostics Market by Product, 2021-2031, $ mn 165
Table 80. South Africa In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn 165
Table 81. South Africa In Vitro Diagnostics Market by End User, 2021-2031, $ mn 165
Table 82. Abbott Laboratories, Inc.: Company Snapshot 171
Table 83. Abbott Laboratories, Inc.: Business Segmentation 172
Table 84. Abbott Laboratories, Inc.: Product Portfolio 172

List of Figures:

Figure 1. Research Method Flow Chart 14
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 17
Figure 3. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031 19
Figure 4. Global In Vitro Diagnostics Market, 2021-2031, $ mn 22
Figure 5. Impact of COVID-19 on Business 27
Figure 6. Primary Drivers and Impact Factors of Global In Vitro Diagnostics Market 29
Figure 7. Leading Causes of Death in the World, 2000 and 2019, million 32
Figure 8. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 33
Figure 9. World Population 65 and Over, % of Total Population, 1950-2060 33
Figure 10. Primary Restraints and Impact Factors of Global In Vitro Diagnostics Market 35
Figure 11. Investment Opportunity Analysis 39
Figure 12. Porter’s Fiver Forces Analysis of Global In Vitro Diagnostics Market 42
Figure 13. Breakdown of Global In Vitro Diagnostics Market by Product, 2021-2031, % of Revenue 47
Figure 14. Global Addressable Market Cap in 2022-2031 by Product, Value ($ mn) and Share (%) 47
Figure 15. Global In Vitro Diagnostics Market by Product: Instruments & Devices, 2021-2031, $ mn 48
Figure 16. Global In Vitro Diagnostics Market by Instruments & Devices: Disposable IVD Devices, 2021-2031, $ mn 49
Figure 17. Global In Vitro Diagnostics Market by Instruments & Devices: Reusable IVD Devices, 2021-2031, $ mn 50
Figure 18. Global In Vitro Diagnostics Market by Product: Reagents & Kits, 2021-2031, $ mn 51
Figure 19. Global In Vitro Diagnostics Market by Product: Software & Services, 2021-2031, $ mn 52
Figure 20. Breakdown of Global In Vitro Diagnostics Market by Technology, 2021-2031, % of Sales Revenue 54
Figure 21. Global Addressable Market Cap in 2022-2031 by Technology, Value ($ mn) and Share (%) 54
Figure 22. Global In Vitro Diagnostics Market by Technology: Clinical Chemistry, 2021-2031, $ mn 55
Figure 23. Global In Vitro Diagnostics Market by Technology: Molecular Diagnostics, 2021-2031, $ mn 56
Figure 24. Global In Vitro Diagnostics Market by Technology: Immuno Diagnostics, 2021-2031, $ mn 57
Figure 25. Global In Vitro Diagnostics Market by Technology: Hematology, 2021-2031, $ mn 58
Figure 26. Global In Vitro Diagnostics Market by Technology: Tissue Diagnostics, 2021-2031, $ mn 59
Figure 27. Global In Vitro Diagnostics Market by Technology: Microbiology, 2021-2031, $ mn 60
Figure 28. Global In Vitro Diagnostics Market by Technology: Coagulation and Hemostasis, 2021-2031, $ mn 61
Figure 29. Global In Vitro Diagnostics Market by Technology: Urinalysis, 2021-2031, $ mn 62
Figure 30. Global In Vitro Diagnostics Market by Technology: Other Technologies, 2021-2031, $ mn 63
Figure 31. Breakdown of Global In Vitro Diagnostics Market by Sample Type, 2021-2031, % of Sales Revenue 65
Figure 32. Global Addressable Market Cap in 2022-2031 by Sample Type, Value ($ mn) and Share (%) 65
Figure 33. Global In Vitro Diagnostics Market by Sample Type: Blood, 2021-2031, $ mn 66
Figure 34. Global In Vitro Diagnostics Market by Sample Type: Mucus, 2021-2031, $ mn 67
Figure 35. Global In Vitro Diagnostics Market by Sample Type: Urine, 2021-2031, $ mn 68
Figure 36. Global In Vitro Diagnostics Market by Sample Type: Other Sample Types, 2021-2031, $ mn 69
Figure 37. Breakdown of Global In Vitro Diagnostics Market by Application, 2021-2031, % of Revenue 71
Figure 38. Global Addressable Market Cap in 2022-2031 by Application, Value ($ mn) and Share (%) 71
Figure 39. Global In Vitro Diagnostics Market by Application: Infectious Diseases, 2021-2031, $ mn 72
Figure 40. Global In Vitro Diagnostics Market by Application: Diabetes, 2021-2031, $ mn 82
Figure 41. Global In Vitro Diagnostics Market by Application: Cancer/Oncology, 2021-2031, $ mn 83
Figure 42. Global In Vitro Diagnostics Market by Application: Cardiology, 2021-2031, $ mn 84
Figure 43. Global In Vitro Diagnostics Market by Application: Autoimmune Disease, 2021-2031, $ mn 85
Figure 44. Global In Vitro Diagnostics Market by Application: Nephrology, 2021-2031, $ mn 86
Figure 45. Global In Vitro Diagnostics Market by Application: Drug Testing, 2021-2031, $ mn 87
Figure 46. Global In Vitro Diagnostics Market by Application: HIV/AIDS, 2021-2031, $ mn 88
Figure 47. Global In Vitro Diagnostics Market by Application: Other Applications, 2021-2031, $ mn 89
Figure 48. Breakdown of Global In Vitro Diagnostics Market by End User, 2021-2031, % of Revenue 91
Figure 49. Global Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%) 91
Figure 50. Global In Vitro Diagnostics Market by End User: Diagnostic Laboratories, 2021-2031, $ mn 92
Figure 51. Global In Vitro Diagnostics Market by End User: Hospitals and Clinics, 2021-2031, $ mn 93
Figure 52. Global In Vitro Diagnostics Market by End User: Homecare Settings, 2021-2031, $ mn 94
Figure 53. Global In Vitro Diagnostics Market by End User: Point-of-Care (POC) Settings, 2021-2031, $ mn 95
Figure 54. Global In Vitro Diagnostics Market by End User: Other End Users, 2021-2031, $ mn 96
Figure 55. Global Market Snapshot by Region 97
Figure 56. Geographic Spread of Worldwide In Vitro Diagnostics Market, 2021-2031, % of Sales Revenue 98
Figure 57. Global Addressable Market Cap in 2022-2031 by Region, Value ($ mn) and Share (%) 99
Figure 58. North American In Vitro Diagnostics Market, 2021-2031, $ mn 102
Figure 59. Breakdown of North America In Vitro Diagnostics Market by Country, 2021 and 2031, % of Revenue 103
Figure 60. Contribution to North America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 104
Figure 61. U.S. In Vitro Diagnostics Market, 2021-2031, $ mn 106
Figure 62. Canada In Vitro Diagnostics Market, 2021-2031, $ mn 108
Figure 63. In Vitro Diagnostics Market in Mexico, 2021-2031, $ mn 110
Figure 64. European In Vitro Diagnostics Market, 2021-2031, $ mn 113
Figure 65. Breakdown of European In Vitro Diagnostics Market by Country, 2021 and 2031, % of Revenue 114
Figure 66. Contribution to Europe 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 115
Figure 67. In Vitro Diagnostics Market in Germany, 2021-2031, $ mn 116
Figure 68. In Vitro Diagnostics Market in U.K., 2021-2031, $ mn 118
Figure 69. In Vitro Diagnostics Market in France, 2021-2031, $ mn 120
Figure 70. In Vitro Diagnostics Market in Spain, 2021-2031, $ mn 122
Figure 71. In Vitro Diagnostics Market in Italy, 2021-2031, $ mn 124
Figure 72. In Vitro Diagnostics Market in Netherlands, 2021-2031, $ mn 126
Figure 73. In Vitro Diagnostics Market in Rest of Europe, 2021-2031, $ mn 128
Figure 74. Asia-Pacific In Vitro Diagnostics Market, 2021-2031, $ mn 131
Figure 75. Breakdown of APAC In Vitro Diagnostics Market by Country, 2021 and 2031, % of Revenue 131
Figure 76. Contribution to APAC 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 133
Figure 77. In Vitro Diagnostics Market in Japan, 2021-2031, $ mn 135
Figure 78. In Vitro Diagnostics Market in China, 2021-2031, $ mn 137
Figure 79. In Vitro Diagnostics Market in Australia, 2021-2031, $ mn 139
Figure 80. In Vitro Diagnostics Market in India, 2021-2031, $ mn 141
Figure 81. In Vitro Diagnostics Market in South Korea, 2021-2031, $ mn 143
Figure 82. In Vitro Diagnostics Market in Rest of APAC, 2021-2031, $ mn 145
Figure 83. South America In Vitro Diagnostics Market, 2021-2031, $ mn 148
Figure 84. Breakdown of South America In Vitro Diagnostics Market by Country, 2021 and 2031, % of Revenue 148
Figure 85. Contribution to South America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 149
Figure 86. In Vitro Diagnostics Market in Argentina, 2021-2031, $ mn 150
Figure 87. In Vitro Diagnostics Market in Brazil, 2021-2031, $ mn 152
Figure 88. In Vitro Diagnostics Market in Chile, 2021-2031, $ mn 154
Figure 89. In Vitro Diagnostics Market in Rest of South America, 2021-2031, $ mn 156
Figure 90. In Vitro Diagnostics Market in Middle East and Africa (MEA), 2021-2031, $ mn 158
Figure 91. Breakdown of MEA In Vitro Diagnostics Market by Country, 2021 and 2031, % of Revenue 158
Figure 92. Contribution to MEA 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 159
Figure 93. In Vitro Diagnostics Market in UAE, 2021-2031, $ mn 160
Figure 94. In Vitro Diagnostics Market in Saudi Arabia, 2021-2031, $ mn 162
Figure 95. In Vitro Diagnostics Market in South Africa, 2021-2031, $ mn 164
Figure 96. Growth Stage of Global In Vitro Diagnostics Industry over the Forecast Period 167

Interested in this report?
Get your FREE sample!

Safe and Secure SSl Encryption

Licensing options

3490
USD

Single User License
Site License
Global User License

How client has rates us?

Requirement Gathering & Methodology

Data Collection Techniques

Our Research Team & Data Sourcing

Data Science & Analytical Tools

Data Visualization & Presentation Skills

Project/ Report Delivery & After Sales Services

Testimonial

READY TO MIX MARKET HAS HELPED US TO UNDERSTAND PRODUCT, PRICE & VARIENTS OF ALL THE COMPETITION INCLUDING SMALL STARTUPS/REGIONAL PLAYERS.

PRODUCT DEVELOPMENT MANAGER

CEO

Vivek Arora

BEING A STARTUP WE WERE NOT AWARE ABOUT E-COMMERCE LOGISTICS, THE REPORT HAS RESOLVED ALL OUR QUERIES. THE TEAM HAVE IN DEPTH KNOWLEDGE OF LOGISTICS. REMARKABLE!!

EXECUTIVE DIRECTOR

Rahul Roy

THE REPORT WAS GOOD FOR OUR STUDY, I WOULD STRONGLY RECOMMEND BONAFIDE RESEARCH. A VERY CUSTOMER CENTRIC AND APPROACHABLE TEAM.

SALES DIRECTOR

Arjun Prasad

THE COMPANY WHICH THOROUGHLY UNDERSTANDS INDIAN CONSUMER AND INDIAN MARKET. WE ARE REALLY HAPPY TO WORK WITH BONAFIDE RESEARCH

MARKETING MANAGER

President

Manish Verma

Bonafide Research did an outstanding work on Global Hand Sanitizer project. It was indeed a comprehensive report that gave us revenue impacting solution enabling us to plan the right move.

MARKETING DIRECTOR

Gautam Saxena

The study done by Bonafide Research was customized with all our needs. We were extremely impressed by the simple but comprehensive presentation of the study and the quality of work done.

PRODUCT MANAGER

Tom Stone

I’m glad I decided to work with you. Thankful to the team for the amazing coordination, it was indeed a good experience, would definitely recommend and come back for future prospects.

Associate Director

Mark Wood

Global In Vitro Diagnostics (IVD) Market 2021-2031

Global In Vitro Diagnostics (IVD) Market 2021-2031